Other tick-borne diseases in europet

Current Problems in Dermatology

Volumn 37, Issue , 2009, Pages 130-154

  Bitam, Idir ^a   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUININE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STEROID; STREPTOMYCIN; TETRACYCLINE; TICK BORNE ENCEPHALITIS VACCINE; ANTIINFECTIVE AGENT; ANTIPROTOZOAL AGENT;

ANAPLASMA MARGINALE; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; ANTIBIOTIC THERAPY; BABESIOSIS; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD SMEAR; BORRELIA; BORRELIA BURGDORFERI; BORRELIA CROCIDURAE; BORRELIA DUTTONII; BORRELIA INFECTION; BORRELIAL HISPANICA; CHEMOPROPHYLAXIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DERMACENTOR; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; EXCHANGE BLOOD TRANSFUSION; FRANCISELLA TULARENSIS; HERXHEIMER REACTION; HUMAN; IMMUNOFLUORESCENCE TEST; IXODES RICINUS; LABORATORY DIAGNOSIS; NONHUMAN; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHIPICEPHALUS SANGUINEUS; RICKETTSIA; RICKETTSIA AESCHLIMANNII; RICKETTSIA CONORII; RICKETTSIA HELVETICA; RICKETTSIA MASSILIAE; RICKETTSIA RAOULTII; RICKETTSIA SIBIRICA; RICKETTSIA SLOVACA; RICKETTSIOSIS; TICK; TICK BORNE DISEASE; TICK BORNE ENCEPHALITIS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; TRANSPORT HOST; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TULAREMIA; WESTERN BLOTTING; ANIMAL; ARTICLE; BACTERIAL INFECTION; DISEASE TRANSMISSION; MICROBIOLOGY; PARASITE VECTOR; PARASITOLOGY; PROTOZOAL INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIPROTOZOAL AGENTS; ARACHNID VECTORS; BACTERIAL INFECTIONS; EUROPE; PROTOZOAN INFECTIONS; TICK-BORNE DISEASES; TICKS;

EID: 67649566119     PISSN: 14215721     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000213072     Document Type: Review

References (128)

1. Centers for Disease Control: Lyme disease - United States, 1987 and 1988. MMWR Morb Mortal Wkly Rep 1989;38:668-672.
2. Spach DH, Liles WC, Campbell GL, et al: Tickborne diseases in the US. N Engl J Med 1993;329:936-947.
3. Myers SA, Sexton DJ: Dermatologic manifestations of arthropod-borne diseases. Infect Dis Clin North Am 1994;8:689-712.
4. Cary NRB, Fox B, Wright DJM, et al: Fatal Lyme carditis and endodermal heterotopia of the atrioventricular node. Postgrad Med J 1990;66:134-136.
5. Paddock CD, Sumner JW, Shore GM, et al: Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol 1997;10:2496-2502.
6. Hardalo CJ, Quagliarello V, Dumler JS: Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis 1995;4:910-914.
7. Kirsch M, Ruben FL, Steere AC, et al: Fatal adult respiratory distress syndrome in a patient with Lyme disease. JAMA 1988;259:2737-2739.
8. Berglund J, Eitrem R, Ornstein K, et al: An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319-1327.
9. Sonenshine DE, Azad AF: Ticks and mites in disease transmission; in Strickland GT (ed): Hunter's Tropical Medicine, ed 7. Philadelphia, WB Saunders, 1991, pp 971-981.
10. Peavy CA, Lane RS, Kleinjan JE: Role of small mammals in the ecology of B. burgdorferi in a periurban park in north coastal California. Exp Appl Acarol 1997;21:569-584.
11. Fritz CL, Kjemtrup AM, Conrad PA, et al: Seroepidemiology of emerging tick-borne infectious diseases in a northern Californian community. J Infect Dis 1997;175:1432-1439.
12. Middleton DB: Tick-borne infections: what starts as a tiny bite may have a serious outcome. Postgrad Med J 1994;5:131-139.
13. Oksi J, Viljanen MK, Kalimo H, et al: Fatal encephalitis caused by concomitant infection with tickborne encephalitis virus and Borrelia burgdorferi. Clin Infect Dis 1993;16:392-396.
14. Strle F, Maraspin V, Lotric-Furlan S, et al: Epidemiologic study of a cohort of adult patients with erythema migrans registered in Slovenia in 1993. Eur J Epidemiol 1996;5:503-507.
15. Santos AS, Bacellar F, Dumler JS: Human Exposure to Anaplasma phagocytophilum in Portugal. Ann NY Acad Sci 2006;1078:100-105.
16. Naranjo V, Ruiz-Fons F, Höfle U, Fernandez de Mera IG, Villanua D, Almazan C, et al: Molecular epidemiology of human and bovine anaplasmosis in southern Europe. Ann NY Acad Sci 2006;1078:95-99.
17. Inokuma H: Vectors and reservoir hosts of Anaplasmataceae; in Raoult D, Parola P (eds): Rickettsial Diseases, ed 1. New York, Informa Healthcare, 2007.
18. Brouqui P, Matsumoto K: Bacteriology and phylogeny of Anaplasmataceae; in Raoult D, Parola P (eds): Rickettsial Diseases, ed 1. New York, Informa Healthcare, 2007.
19. Barlough JE, Madigan JE, Kramer VL, Clover JR, Hui LT, Vredevoe LK: Ehrlichia phagocytophila genogroup rickettsiae in ixodid ticks from California collected in 1995 and 1996. J Clin Microbiol 1997;35:2018-2021.
20. Dumler JS, Madigan JE, Pusterla N, Bakken JS: Ehrlichiosis in humans: epidemiology, clinical presentation, d iagnosis, a nd treatment. Clin Infect Dis 2007;45:45-51.
21. Chen S, Dumler JS, Bakken JS, Walker DH: Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-595.
22. Petrovec M, Lotric Furlan S, Avsic Zupanc T, Strle F, Brouqui P, Roux V, et al: Human disease in Europe caused by a granulocytic Ehrlichia species. J Clin Microbiol 1997;35:1556-1559.
23. Cinco M, Padovan D, Murgia R, Heldtander M, Engvall EO: Detection of HGE agent-like Ehrlichia in Ixodes ricinus ticks in northern Italy by PCR. Wien Klin Wochenschr 1998;110:898-900.
24. Nuti M, Serafini DA, Bassetti D, Ghionni A, Russino F, Rombola P, et al: Ehrlichia infection in Italy. Emerg Infect Dis 1998;4:663-665.
25. Blanco JR, Oteo JA: Human granulocytic ehrlichiosis in Europe. Clin Microbiol Infect 2002;8:763-772.
26. Arnez M, Petrovec M, Lotric-Furlan S, Zupanc AT, Strle F: First European pediatric case of human granulocytic ehrlichiosis. J Clin Microbiol 2001;39:4591-4592.
27. Lotric-Furlan S, Petrovec M, Zupanc T, Nicholson W, Summer J, Childs J, et al: Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four pat ients from Slovenia. Clin Infect Dis 1998;27:424-428.
28. van Dobbenburgh A, van Dam AP, Fikrig E: Human granulocytic ehrlichiosis in western Europe. New Engl J Med 1999;340:1214-1216.
29. Oteo JA, Blanco JR, Martinez de Artola V: First report of human granulocytic ehrlichiosis from southern Europe (Spain). Emerg Infect Dis 2000;6:430-432.
30. Bjoersdorff A, Wittesjö B, Berglund J, Massung RF, Eliasson I: Human granulocytic ehrlichiosis as a common cause of tick-associated fever in southeast Sweden: report from a prospective clinical study. Scand J Infect Dis 2002;34:187-191.
31. Misic-Majerus LJ, Bujic N, Madjaric V, Janes-Poje V: First description of the human granulocytic ehrlichiosis in Croatia. Clin Microbiol Infect 2000;25:194-195.
32. Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawiki W, Sulek K: First cases of acute human granulocytic ehrlichiosis in Poland. Eur J Clin Microbiol 2001;20:196-198.
33. Remy V, Hansmann Y, De Martino S, Christmann D, Brouqui P: Human anaplasmosis presenting as atypical pneumonitis in France. Clin Infect Dis 2003;37:846-848.
34. Olano JP, Walker DH: Human ehrlichioses. Med Clin North Am 2002;86:375-392.
35. Bakken JS, Dumler JS: Human granulocytic ehrlichiosis. Clin Infect Dis 2000;31:554-560.
36. Parola P, Davoust B, Raoult D: Tick- and flea-borne rickettsial emerging zoonoses. Vet Res 2005;36:469-492.
37. Rikihisa Y, Stills H, Zimmerman G: Isolation and continuous culture of Neorickettsia helminthoeca in a macrophage cell line. J Clin Microbiol 1991;29:1928-1933.
38. Bakken JS, Dumler JS: Clinical diagnosis and treatment of human granulotropic anaplasmosis. Ann NY Acad Sci 2006;1078:236-247.
39. Horowitz HW, Aguero-Rosenfeld ME, Mckenna DF, Holmgren D, Hsieh TC, Varde SA, et al: Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases. Clin Infect Dis 1998;27:1314-1317.
40. Doyle CK, Labruna MB, Breitschwerdt EB, Tang YW, Corstvet RE, Hegarty BC, et al: Detection of medically important Ehrlichia by quantitative multicolor TaqMan real-time polymerase chain reaction of the dsb gene. J Mol Diagn 2005;7:504-510.
41. Bakken JS, Dumler JS: Ehrlichia and Anaplasma species; in Yu V, Weber R, Raoult D (eds): Antimicrobial Therapy and Vaccines, ed 2. New York, Apple Trees Productions, 2002.
42. Maurin M, Bakken JS, Dumler JS: Antibiotic susceptibilities of Anaplasma (Ehrlichia) phagocytophilum strains from various geographic areas in the United States. Antimicrob Agents Chemother 2003;47:413-415.
43. Van Dam AP, van Gool T, Weststeyn JCFM, Dankert J: Tick-borne relapsing fever imported from West Africa: diagnosis by quantitative buffy coat analysis and in vitro culture of Borrelia crocidurae. J Clin Microbiol 1999;37:2027-2030.
44. Lecompte Y, Trape JF: La fièvre récurrente à tique d'Afrique de l'ouest. Ann Biol Clin (Paris) 2003;61:541-548.
45. Brouqui P, Raoult D: Arthropod-borne diseases in homeless. Ann NY Acad Sci 2006;1078:223-235.
46. Rebaudet S, Parola P: Epidemiology of relapsing fever borreliosis. FEMS Immunol Med Microbiol 2006;48:11-15.
47. Cutler SJ, Browning P, Scott JC: Ornithodoros moubata, a soft tick vector for Rickettsia in east Africa? Ann NY Acad Sci 2006;1078:373-377.
48. Parola P, Raoult D: Ticks and tickborne bacterial diseases in humans: an emerging infectious threat. Clin Infect Dis 2001;32:897-928.
49. Vial L, Diatta G, Tall A, et al: Incidence of tickborne relapsing fever in West Africa: longitudinal study. Lancet 2006;368:37-43.
50. Estrada-Pena A, Jongejan F: Ticks feeding on humans: a review of records on human-biting Ixodoidea with special reference to pathogen transmission. Exp Appl Acarol 1999;23:685-715.
51. Wplosz B, Mihaila-Amrouche L, Baixenh MT, et al: Imported tick-borne relapsing fever, France. Emerg Infect Dis 2005;11:1801-1803.
52. Felsenfeld O: Borreliae, human relapsing fever, and parasite-vector-host relationships. Bacteriol Rev 1965;29:46-74.
53. Anda P, Sanchez-Yebra W, del Mar Vitutia M, et al: A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet 1996;348:162-165.
54. Cutler SJ: Possibilities for relapsing fever re-emergence. Emerg Infect Dis 2006;12:369-374.
55. Johnson WD: Borrelia species (relapsing fever); in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 4. New York, Churchill Livingstone, 1995, pp 1816-1819.
56. Johnson WD, Golightly LM: Borrelia species (relapsing fever); in Mandell GL, Bennett JE, Dolin R (eds): Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, ed 5. New York, Churchill Livingstone, 2000.
57. Dupont HT, La Scola B, Williams R, Raoult D: A focus of tick-borne relapsing fever in Southern Zaire. Clin Infect Dis 1997;25:139-144.
58. Bratton RL, Corey GR: Tick-borne disease. Am Family Physician 2005:72:2323-2330.
59. Cutler SJ, Akintunde COK, Moss J, et al: Successful in vitro cultivation of Borrelia duttonii and its comparison with Borrelia recurrentis. Int J Syst Bacteriol 1999;49:1793-1799.
60. Cutler SJ, Fekade D, Hussein K, et al: Successful invitro cultivation of Borrelia recurrentis. Lancet 1994;343:242.
61. Marti Ras N, La Scola B, Postic D, et al: Phylogenesis of relapsing fever Borrelia spp. Int J Syst Bact 1996;46:859-865.
62. Cadavid D, Barbour AG: Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 1998;26:151-164.
63. Müller W, Bocklish H, Schüler G, Hotzel H, Neubauer H, Otto P: Detection of Francisella tularensis subsp. holarctica in a European brown hare (Lepus europaeus) in Thuringia, Germany. Vet Microbiol 2007;123:225-229.
64. Jiang J, Parker CE, Fuller JR, Kawula TH, Borchers CH: An immunoaffinity tandem mass spectrometry (iMALDI) assay for detection of Francisella. Ana l Chim Acta 2007;605:70-79.
65. Chaudhui RR, Reu CP, Desmond L, et al: Genome sequencing shows that European isotopes of Francisella tularensis subspecies tularensis are almost identical to US laboratory strain Schu S 4. PloS ONE 2007;2:e352.
66. Gurycova D: First isolation of Francisella tularensis subsp. tularensis in Europe. Eur J Epidemiol 1998;14:797-802.
67. Eliasson H, Lindbäck J, Nuorti J, Arneborn M, Giesecke J, Tegnell A: The 2000 tularemia outbreak: a case-control study of risk factors in disease-endemic and emergent areas, Sweden. Emerg Infect Dis 2002;8:956-960.
68. Reintjes R, Dedushaj I, Gjini A, et al: Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg Infect Dis 2002;8:969-973.
69. Johansson A, Forsman M, Sjöstedt A: The development of tools for diagnosis of tularemia and typing of Francisella tularensis. APMIS 2004;112:898-907.
70. De Cavalho IL, Escudero R, Garcia-Amil C, Falcao H, Anda P, Nuncio MS: Francisella tularensis, Portugal. Emerg Infect Dis 2007;13:666-667.
71. Bratton RL, Corey GR: Tick-borne disease. Am Fa m Phys 2005;71:2323-2330.
72. Dennis DT, Inglesby TV, Henderson DA, et al: Tularemia as a biological weapon: medical and Public Hea lth Management. JAMA 2001;285:2763-2773.
73. Evans M, Gregory D, Schaffner W, McGee ZA: Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 1985;64:251-269.
74. Bossi P, Tegnell A, Baka A, et al: Bichat guidelines for the clinical management of tularaemia and bioterrorism-related tularaemia. Euro Sur veill 2004;9: E9-E10.
75. Miller RP, Bates JH: Pleuropulmonary tularemia: a re view of 29 patients. Am Rev Respir Dis 1969;99:31-41.
76. Rubin SA: Radiographic spectrum of pleuropulmonary tularemia. AJR Am J Roentgenol 1978;131:277-281.
77. Forsman M, Kuoppa K, Sjöstedt A, Tärnvik A: Use of RNA hybridization in the diagnosis of a case of ulceroglandular tularemia. Eur J Clin Microbiol Infect Dis 1990;9:784-785.
78. Ellis J, Oyston PC, Green M, Titball RW: Tularemia. Clin Microbiol Rev 2002;15:631-646.
79. Beers MH, Berkow R: The Merck Manual of Diagnosis and Therapy, ed 17. Whitehouse Station, Merck Research Laboratories, 1999.
80. Rizzoli A, Rosa R, Mantelli B, et al: Ixodes ricinus, transmitted diseases and reservoirs (in Italian). Parassitologia 2004;46:119-122.
81. Kaiser R: The clinical and epidemiological profile of tick-borne encephalitis in southern Germany 1994-1998: a prospective study of 656 patients. Brain 1999;122:2067-2078.
82. Kaiser R, Kern A, Kampa D, Neumannhaefelin D: Prevalence of antibodies to Borrelia burgdorferi and tick-borne encepha litis vir us in an endemic region in southern Germany. Zentralbl Bakteriol 1997;286:534-541.
83. Pugliesse A, Beltramo T, Torre D: Seroprevalence study of tick-borne encephalitis, Borrelia burgdorferi, dengue and Toscana virus in Turin province. Cell Biochem Funct 2007;25:185-188.
84. Skarphedinsson S, Jensen PM, Kristiansen K: Survey of tick-borne infections in Denmark. Emerg Infect Dis 2005;11:1055-1061.
85. Haglund M, Vene S, Forsgren M, et al: Characterization of human tick-borne encephalitis virus from Sweden. J Med Virol 2003;71:610-621.
86. Jaussaud R, Magy N, Strady A, Dupond JL, Deville JF: Tick-borne encephalitis. Rev Med Interne 2001;22:542-548.
87. Charrel RN, Attoui H, Butenko AM, et al: Tickborne virus diseases of human interest in Europe. Clin Microbiol Infect 2004;10:1040-1055.
88. Kondrusik M, Biedzinska T, Pancewicz S, et al: Tick-borne encephalitis (TBE) cases in Bialostocki and Podlaski regions in years 1993-2002. Przegl Epidemiol 2004;58:273-280.
89. Gritsun TS, Nuttall PA, Gould EA: Tick-borne flaviviruses. Adv Virus Res 2003;61:317-371.
90. Ackermann R, Krüger K, Roggendorf M, et al: Spread of early summer meningoencephalitis in the Federal Republic of Germany. Dtsch Med Wochenschr 1986;111:927-933.
91. Kaiser R: Tick-borne encephalitis (TBE) in Germany and clinical course of the disease. Int J Med Microbiol 2002;291(suppl 33):58-61.
92. Seligman SJ, Gould EA: Life flavivirus vaccines: reasons for caution. Lancet 2004;363:2073-2075.
93. Pugliesse A, Beltramo T, Torre D: Emerging and re-emerging viral infections in Europe. Cell Biochem Funct 2007;25:1-13.
94. Sambri V, Marangoni A, Storni E, et al: Tick-borne zoonosis: selected clinical and diagnostic aspects. Parassitologia 2004;46:109-113.
95. Holbrook MR, Shope RE, Barrett ADT: Use of recombinant E protein domain III-based enzymelinked immunosorbent assays for differentiation of tick-borne encephalitis serocomplex flaviviruses from mosquito-borne flaviviruses. J Clin Microbiol 2004;42:4101-4110.
96. Schwaiger M, Cassinotti P: Development of a quantitative real-time RT-PCR assay with internal control for the laboratory detection of tick-borne encephalitis virus (TBEV) RNA. J Clin Virol 2003;27:136-145.
97. Kunz C: TBE vaccination and the Austrian experience. Vaccine 2003;21:S50-S55.
98. Gefland JA: Babesia; in Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Diseases, ed 4. New York, Churchill Livingstone, 1995, pp 2497-2499.
99. Boustani MR, Gelfand JA: Babesiosis. Clin Infect Dis 1996;22:611-615.
100. Pruthi RK, Marshall WF, Wiltsie JC, Persing DH: Huma n babesiosis. Mayo Clin Proc 1995;70:853-862.
101. Skrabalo Z, Deanovic Z: Piroplasmosis in man. Doc Med Geogr Trop 1957;9:11-16.
102. Gorenflot AK, Moubri AK, Precigout E, Carcy B, Schetters TP: Human babesiosis. Ann Trop Med Parasit 1998;92:489-500.
103. Denes E, Rogez JP, Dardé ML, Weinbreack P: Management of Babesia divergens babesiosis without a complete course of quinine treatment. Eur J Clin Microbiol Infect Dis 1999;18:672-673.
104. Spach DH, Liles W, Campbell G, Quick R, Anderson D, Fritsche T: Tick-borne diseases in the United States. N Engl J Med 1993;329:936-947.
105. Ruebush TK, Cassaday PB, Marsh HJ, et al: Human babesiosis on Nantucket Island: clinical features. Ann Intern Med 1977;86:6-9.
106. Etkind P, Piesman J, Ruebush TK 2nd, Spielman A, Juranek DD: Methods for detecting Babesia microti infection in wild rodents. J Parasitol 1980;66:107-110.
107. Telford SR 3rd, Spielman A: Babesiosis of humans; in Collier L, Balows A, Sussman M, Kreier JP (eds): Topley and Wilson's Microbiology and Microbial Infections, ed 9. London, Edward Arnold, 1997.
108. Persing DH, Mathiesen D, Marshall WF, et al: Detection of Babesia microti by polymerase chain reaction. J Clin Microbiol 1992;30:2097-2103.
109. Homer MJ, Aguilar-Delfin I, Telford SR 3rd, Kranse PJ, Persing DH: Babesiosis. Clin Microbiol Rev 2000;13:451-469.
110. Lodes MJ, Houghton RL, Bruinsma ES, et al: Serological expression cloning of novel immunoreactive antigens of Babesia microti. Infect Immun 2000;68:2783-2790.
111. Chauvin A, L'Hotis M, Valentin A, et al: Babesia divergens: an ELISA with soluble parasite antigen for monitoring the epidemiology of bovine babesiosis. Parasite 1995;2:257-262.
112. Parola P, Paddock CD, Raoult D: Tick-borne rickettsioses around the world: emerging diseases challenging old concepts. Clin Microbiol Rev 2005;18:719-756.
113. Brouqui P, Matsumoto K: Bacteriology and phylogeny of Anaplasmataceae; in Raoult D, Parola P (eds): Rickettsial Diseases, ed 1. New York, Informa Healthcare, 2007.
114. Valero A: Rocky Mountain spotted fever in Palestine. Harefuah 1949;36:99-101.
115. Zhu Y, Fournier PE, Eremeeva M, Raoult D: Proposal to create subspecies of Rickettsia conorii based on multi-locus sequence typing and an emended description of Rickettsia conorii. BMC Microbiol 2005;5:11.
116. de Sousa R, Santos-Silva M, Santos AS, et al: Rickettsia conorii Israeli tick typhus strain isolated from Rhipicephalus sanguineus ticks in Portugal. Vector Borne Zoonotic Dis 2007;7:444-447.
117. Giammanco GM, Vitale G, Mansueto S, Capra G, Caleca MP, Ammatuna P: Presence of R. conorii subsp. israelensis, the causative agent of Israeli spotted fever, in Sicily, Italy, ascertained in a retrospective study. J Clin Microbiol 2005;43:6027-6031.
118. Raoult D, Roux V: Rickettsioses as paradigms of new or emerging infectious diseases. Clin Microbiol Rev 1997;10:694-719.
119. Fournier PE, Dumler JS, Greub G, Zhang JZ, Wu YM, Raoult D: Gene sequence-based criteria for identification of new Rickettsia isolates and description of Rickettsia heilongjiangensis sp. nov. J Clin Microbiol 2003;41:5456-5465.
120. Fournier PE, Gouriet F, Brouqui P, Lucht F, Raoult D: Lymphangitis-associated rickettsiosis, a new rickettsiosis caused by Rickettsia sibirica mongolotimonae: seven new cases and review of the literature. Clin Infect Dis 2005;40:1435-1444.
121. Rehacek J: Rickettsia slovaca, the organism and its ecology. Acta Sci Nat Brno 1984;18:1-50.
122. Gouriet F, Rolain JM, Raoult D: Rickettsia slovaca infection, France. Emerg Infect Dis 2006;12:521-523.
123. Beati L, Meskini M, Thiers B, Raoult D: Rickettsia aeschlimannii sp. nov., a new spotted fever group rickettsia associated with Hyalomma marginatum ticks. Int J Syst Bacteriol 1997;47:548-554.
124. Pretorius AM, Birtles RJ: Rickettsia aeschlimannii: a new pathogenetic spotted fever group Rickettsia, South Africa. Emerg Infect Dis 2002;8:874.
125. Fournier PE, Gunnenberger F, Jaul hac B, Gastinger G, R aou lt D: Ev idence of Rickettsia helvetica infection in humans, Eastern France. Emerg Infect Dis 2000;6:389-392.
126. Fournier PE, Allombert C, Supputamongkol Y, Caruso G, Brouqui P, Raoult D: Aneruptive fever associated with antibodies to Rickettsia helvetica in Europe and Thailand. J Clin Microbiol 2004;42:816-818.
127. Nilsson K, Lindquist O, Pahlson C: Association of Rickettsia helvetica with chronic perimyocarditis in sudden cardiac death. Lancet 1999;354:1169-1173.
128. Mediannikov O, Parola P, Raoult D: Other tickborne rickettsioses; in Raoult D, Parola P (eds): Rickettsial Diseases. New York, Informa Healthcare, 2007, pp 139-162.